enzastaurin has been researched along with Uveal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fletcher, JA; Giobbie-Hurder, A; Hodi, FS; Wu, X; Zhu, M | 1 |
1 other study(ies) available for enzastaurin and Uveal Neoplasms
Article | Year |
---|---|
The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma.
Topics: Apoptosis; Bromodeoxyuridine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Drug Screening Assays, Antitumor; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Protein alpha Subunits; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Indoles; Isoenzymes; Melanoma; Mitogen-Activated Protein Kinase Kinases; Molecular Sequence Data; Mutation; Protein Kinase C; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Uveal Neoplasms | 2012 |